Targeting PAK4 inhibits Ras-mediated signaling and multiple oncogenic pathways in high-risk Rhabdomyosarcoma-Reference-Cited by-同舟云学术

Targeting PAK4 inhibits Ras-mediated signaling and multiple oncogenic pathways in high-risk Rhabdomyosarcoma

Published:2020-11-09 Issue: Volume: Page:canres.0854.2020
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Dasgupta Atreyi,Sierra Laura,Tsang Susan V.,Kurenbekova Lyazat,Patel Tajhal,Rajapakshe Kimal,Shuck Ryan L.,Rainusso Nino,Landesman Yosef,Unger Thaddeus,Coarfa Cristian^ORCID,Yustein Jason T.^ORCID

Funder

Center for Strategic Scientific Initiatives, National Cancer Institute

Alex's Lemonade Stand Foundation for Childhood Cancer

Cancer Prevention and Research Institute of Texas

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4;MedComm;2024-09

2. PAK4 Is Involved in the Stabilization of PD-L1 and the Resistance to Doxorubicin in Osteosarcoma and Predicts the Survival of Diagnosed Patients;Cells;2024-08-28

3. Channeling Nicotinamide Phosphoribosyltransferase (NAMPT) to Address Life and Death;Journal of Medicinal Chemistry;2024-04-05

4. Interaction between p21‐activated kinase 4 and β‐catenin as a novel pathway for PTH‐dependent osteoblast activation;Journal of Cellular Physiology;2024-03-18

5. Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside;Frontiers in Oncology;2024-02-02